Evidence map›Paper›PMID 22550631›Full record

ArticleParasite (Paris, France)2012

Induction of T helper 1 response by immunization of BALB/c mice with the gene encoding the second subunit of Echinococcus granulosus antigen B (EgAgB8/2).

H Boutennoune, A Qaqish, M Al-Aghbar, S Abdel-Hafez, K Al-Qaoud

Abstract read
In one paragraph

Article in Parasite (Paris, France), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Frontiers in cellular and infection microbiology · 2025
    Article
  2. Immunoprotection of recombinant Eg.myophilin againstExperimental and therapeutic medicine · 2016
    Article
  3. Article
  4. Mechanism of protective immunity by vaccination with recombinantExperimental and therapeutic medicine · 2015
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

H BoutennouneDepartment of Biological Sciences, Yarmouk University, Irbid, Jordan.
A Qaqish
M Al-Aghbar
S Abdel-Hafez
K Al-Qaoud

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A pre-designed plasmid containing the gene encoding the second subunit of Echinococcus granulosus AgB8 (EgAgB8/2) was used to study the effect of the immunization route on the immune response in BALB/c mice. Mice were immunized with pDRIVEEgAgB8/2 or pDRIVE empty cassette using the intramuscular (i.m.), intranasal (i.n.) or the epidermal gene gun (g.g.) routes. Analysis of the antibody response and cytokine data revealed that gene immunization by the i.m. route induced a marked bias towards a T helper type 1 (Th1) immune response as characterized by high IFN-γ gene expression and a low IgG1/IgG2a reactivity index (R.I.) ratio of 0.04. The i.n. route showed a moderate IFN-γ expression but a higher IgG1/IgG2a R.I. ratio of 0.25 indicating a moderate Th1 response. In contrast, epidermal g.g. immunization induced a Th2 response characterized by high IL-4 expression and the highest IgG1/IgG2a R.I. ratio of 0.58. In conclusion, this study showed the advantage of genetic immunization using the i.m. route and i.n. over the epidermal g.g. routes in the induction of Th1 immunity in response to E. granulosus AgB gene immunization.

Indexed as

Administration, IntranasalAnimalsAntibodies, HelminthBiolisticsDNA, HelminthEchinococcosisEchinococcus granulosusFemaleGene ExpressionImmunization, SecondaryImmunoglobulin GInjections, IntramuscularInterferon-gammaInterleukin-4LipoproteinsMiceAntibodies, Helminthantigen B, Echinococcus granulosusDNA, HelminthImmunoglobulin GInterferon-gammaInterleukin-4LipoproteinsVaccines, DNA

Identifiers

PMID22550631
PMCPMC3671439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.